Wynzora

Wynzora combines betamethasone and calcipotriol for topical treatment of plaque psoriasis. This corticosteroid and vitamin D analog blend helps reduce inflammation and skin cell overgrowth. Suitable for adults seeking localized psoriasis relief.

Wynzora is used to treat mild to moderate plaque psoriasis in adults. It works by reducing skin inflammation and slowing the rapid growth of skin cells. People often ask, what is Wynzora used for, and the answer is managing psoriasis symptoms like red, scaly patches. This medication is applied directly to affected skin areas as directed.

Wynzora helps improve the appearance of psoriatic plaques by reducing redness and scaling. Users may notice smoother skin within weeks of consistent application. Some people experience temporary skin irritation or dryness at the application site. These effects are generally mild and improve over time.

Wynzora should only be used on the skin as directed by a healthcare provider. Avoid applying to face, groin, or underarms unless specifically instructed. Do not use on broken or infected skin. Keep the medication away from eyes and mucous membranes. Wash hands after application unless treating hand areas.

Topical corticosteroids like betamethasone may interact with other skin treatments, especially strong acids or alcohol-based products. Calcipotriol can interact with high-dose vitamin D supplements. Avoid using Wynzora with other psoriasis medications unless approved by a doctor. Inform your healthcare provider about all products you use on your skin.